Boleslav N. Levitan

Boleslav N. Levitan

Auto-generated profile, based on publicly available information

Boleslav N. Levitan

Astrakhan State Medical University

Research Focus & Metrics

Academic Career Length

45Years (1982-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 August 2019 in Therapy
Verified
Journal Article
Closed access
GGGolubkina E.V. Golubkina
Golubkina E.V. Golubkina
LLLevitan B.N. Levitan
Levitan B.N. Levitan
UUUmerova A.R. Umerova
Umerova A.R. Umerova
KNKamneva N.V. Kamneva N
Kamneva N.V. Kamneva N
DRDepartment of clinical pharmacology of Astrakhan State medical University of the Ministry of Healthcare of Russia
Department of clinical pharmacology of Astrakhan State medical University of the Ministry of Healthcare of Russia
DRDepartment of propaedeutics of internal diseases of Astrakhan State medical University of the Ministry of Healthcare of Russia
Department of propaedeutics of internal diseases of Astrakhan State medical University of the Ministry of Healthcare of Russia

25 June 2021 in Antibiot Khimioter = Antibiotics and Chemotherapy
Verified
Journal Article
Closed access
PDF file
EGE. V. Golubkina
E. V. Golubkina
VSV. M. Sorokin
V. M. Sorokin
BLB. N. Levitan
B. N. Levitan
AUA. R. Umerova
A. R. Umerova
NKN. V. Kamneva
N. V. Kamneva
Relevance. If we reduce the treatment exclusively to the eradication of Helicobacter pylori (Hp), the question of monitoring the results of anti-Hp therapy is controversial, given the widely known data on the detection of Hp, including virulent strains of Hp, in most healthy individuals.The aim of the study: to track the dynamics of stomach colonization with various Hp strains in patients with gastric ulcer and duodenal ulcer (PUD) immediately after the use of standard three-component anti-Hp therapy (AHT) and 1.5–2 months after AHT.Methods. Genotyping of Hp strains was carried out by the VNTR method together with the determination of the cagA gene.Results. Assessment of the results of AHT in the form of «eradication of Hp — re-detection of Hp» (i. e., without taking the determination of Hp strains into account) showed less reliability in the differences than the «eradication — preservation of the strain or change of the strain» score in patients with PUD; in addition, the differences between the initial bacteriological picture and that observed immediately after AHT were on the verge of reliability, while the differences between the initial bacteriological picture and that observed after 1.5–2 months had a high degree of reliability. The number of eradications increased (eradication achieved immediately after AHT was not preserved, except for one) and the number of cagA-containing strains decreased (due to new eradication detected at late follow-up periods and due to a change in strains) in long-term follow-up in patients with PUD.Conclusion. Since all patients with PUD achieved clinical remission, which lasted for the next 1.5–2 months, the success of AHT should not be unambiguously associated with the eradication of Hp; the restoration of the organism's colonization resistance to Hp after a course of therapy is more likely.

27 November 2020 in Effective Pharmacotherapy
Verified
Journal Article
Closed access
VUVolgograd State Medical University
Volgograd State Medical University
VSV.V. Skvortsov
V.V. Skvortsov
BLB.N. Levitan
B.N. Levitan
AGA.N. Gorbac
A.N. Gorbac
AUAstrakhan State Medical University
Astrakhan State Medical University
This article provides information on the epidemiology and etiopathogenesis of echinococcosis and other parasitic diseases affecting the liver. The modern classification of liver echinococcosis, clinical manifestations of this disease, as well as methods of laboratory and instrumental diagnostics, basic approaches to therapy are presented

17 January 2022 in Medical alphabet
Verified
Journal Article
Closed access
PDF file
BLB. N. Levitan
B. N. Levitan
VSV. V. Skvortsov
V. V. Skvortsov
PSP. D. Samokhvalova
P. D. Samokhvalova
Peptic ulcer is a chronic recurrent disease, accompanied by alternating periods of exacerbation and remission, its main feature is the formation of an ulcer in the wall of the stomach and (or) duodenum, penetrating – in this difference from superficial damage to the mucous membrane (erosions) – into the submucosal layer. The etiology is the appearance of Helicobacter pylori (H. pylori) falling into favorable conditions with weakened microfl and the presence of aggressive factors from the environment. In the pathogenesis of peptic ulcer disease, thinning of the gastrointestinal mucosa and violation of compensation mechanisms at the local level are of paramount importance. An important role in the diagnosis is given to a carefully collected anamnesis and complaints of the patient, supplemented by physical examinations, laboratory and instrumental examination methods. The treatment of patients is based on modern methods of treatment, where the latest drugs with proven effi  and well-proven in clinical practice are used, consistent with the international recommendations of the Maastricht V / Florence Consensus, where anti-helicobacter therapy is mandatory for patients with peptic ulcer and chronic gastritis. Currently, treatment is still based on a combination of antimicrobial agents (amoxicillin, clarithromycin, metronidazole), and antisecretory agents (proton pump inhibitors). Standard triple therapy, which includes PPIs and two antibiotics (clarithromycin and amoxicillin/metronidazole) are widely used as a main-line regimen for the treatment of infection. In addition, the concomitant use of alternative medicine is important for the emergence of adaptive or synergistic effects against H. pylori infection.

1 January 2005
Verified
Journal Article
Closed access
EPE A Popov
E A Popov
BLB N Levitan
B N Levitan
LAL P Alekseev
L P Alekseev
OPO A Pronina
O A Pronina
SSS V Suchkov
S V Suchkov

10 November 2017 in Тромбоз, гемостаз и реология
Verified
Journal Article
Closed access
БЛБолеслав Наумович Левитан
Болеслав Наумович Левитан
Цель исследования: установление связи изменений концентраций антиэндотоксиновых антител (АЭА) и фактора некроза опухолей (ФНО) с состоянием системы гемостаза и фибринолиза у больных хроническим гепатитом (ХГ) и циррозом печени (ЦП). Материалы и методы. Обследовано 37 больных ХГ и 60 — с ЦП. Контрольную группу составили 30 здоровых доноров. Результаты. При ХГ повышение АЭА выявлено в 51,3% случаев, а снижение — в 40,5%; при ЦП — в 46,6% и 44,2% случаев, соответственно. Значения ФНО при хронических диффузных заболеваниях печени (ХДЗП) были достоверно повышены, причем у больных ЦП они были выше, чем при ХГ. Анализ динамики факторов гемостаза и фибринолиза в двух подгруппах больных (I — концентрация АЭА]≤]10 мкг/мл, II — АЭА]>]10 мкг/мл) показал, что при повышении содержания АЭА чаще наблюдались явления гипокоагуляции, гиперфибринолиза, появление маркеров гипокоагуляционной фазы ДВС. Заключение. Полученные данные свидетельствуют о важном патогенетическом значении синдрома эндотоксемии в развитии нарушений гемостаза и фибринолиза при ХДЗП. Предлагается использовать определение содержания АЭА и ФНО для оценки выраженности гемокоагуляционных нарушений и в качестве предикторов развития ДВС-синдрома у больных ХГ и ЦП. Aim: to find the associations of anti-endotoxin antibodies (AEA) and tumor necrosis factor (TNF) with hemostasis and fibrinolysis in patients with chronic hepatitis (CH) and liver cirrhosis (LC). Materials and methods. We examined 37 patients with CH, 60 patients with LC, and 30 healthy donors as control group. Results. In patients with CH the increased AEA content was present in 51,3%, the reduced AEA content – in 40,5%. In patients with LC elevated AEA content was revealed in 46,6% and the reduced AEA — in 44,2%. TNF was signifi cantly elevated in all patients, and patients with LC had higher TNF than patients with CH. The comparison between two subgroups (I — AEA≤10 μg/ml, II — AEA>10 μg/ml) showed that increased AEA had mostly associated with hypocoagulation, hyperfibrinolysis, and hypocoagulation phase of DIC. Conclusion. The results show that the endotoxinemia plays important pathogenetic role for the development of both hemostasis and fibrinolysis disorders. We propose to use AEA and TNF contents to assess the severity of coagulation failure as well as a predictor of DIC-syndrom in patients with CH and LC.